Hinge Health to Buy Cylinder Health in $105 Million Cash Deal
The acquisition would extend Hinge Health’s AI-powered care platform into chronic digestive care through a single app.
Hinge Health, Inc. (HNGE) agreed to acquire Cylinder Health, Inc. for $105 million in cash, expanding the digital-care provider beyond its existing back, joint, pelvic and migraine programs into support for chronic digestive conditions. The companies entered into a definitive agreement for the all-cash transaction, which Hinge Health expected to complete in the third quarter of 2026.
The acquisition remained subject to customary closing conditions. Hinge Health didn’t disclose a cash price for each Cylinder share, a transaction premium or additional financial terms. The announced consideration established the size of the commitment while leaving the company’s rollout plan, expected to begin with a new product in 2027, as the central measure of the deal’s strategic impact.
Hinge Health said the combination would pair Cylinder’s clinical expertise and existing market footprint with its own AI-powered care model and technology platform. The companies planned to deliver that support through a single app expected to launch in 2027, giving Hinge Health a route to serve members whose digestive conditions overlap with the health needs already addressed by its platform.
“Many people we already serve for back, joint, pelvic, and migraine care also have chronic digestive conditions. After spending time with Terry Boch and the Cylinder team, it’s clear that Cylinder gives us a running start in a category with significant unmet need,” Hinge Health co-founder and Chief Executive Daniel Perez said.
The transaction followed Hinge Health’s broader effort to expand the range of conditions treated through its technology. The company recently introduced a migraine-care program and described that launch as part of its ambition to move beyond digital physical therapy and automate healthcare delivery at scale. Hinge Health reported $182.3 million in first-quarter 2026 revenue, up 47% from a year earlier, and had $407.1 million in cash, cash equivalents, marketable securities and restricted cash at the end of March.
Hinge Health subsequently raised its full-year 2026 revenue forecast to between $818 million and $824 million and projected a 27% non-GAAP operating margin at the midpoint. Against that growth plan, Cylinder would add a new clinical category and an established footprint rather than requiring Hinge Health to build its digestive-care offering entirely from the ground up. Completion of the deal and delivery of the planned 2027 app will determine how quickly the company can turn that expansion into a broader care relationship with members.